"L’hôpital Edouard Herriot dispose de services d’excellence dans quasiment toutes les spécialités médicales et chirurgicales, avec des services phares : la chirurgie d’urgence, la chirurgie orthopédique, les transplantations et l’immunologie, la rhumatologie, l’hépato-gastroentérologie, la médecine et la chirurgie vasculaires, la néphrologie-dialyse, la médecine du vieillissement, le traitement des grands brulés…"

During the past decade, Hôpital Edouard Herriot conducted 215 clinical trials. In the 10-year time frame, 215 clinical trials started and 48 clinical trials were completed, i.e. on average, 22.3% percent of trials that started reached the finish line to date. In the past 5 years, 111 clinical trials started and 29 clinical trials were completed. i.e. 26.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Edouard Herriot" #1 sponsor was "Hospices Civils de Lyon" with 73 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 15 trials sponsored, "Centre Hospitalier Universitaire de Saint Etienne" with 14 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 14 trials sponsored and "UNICANCER" with 14 trials sponsored. Other sponsors include 284 different institutions and companies that sponsored additional 160 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Edouard Herriot" #1 collaborator was "Ministry of Health, France" with 16 trials as a collaborator, "Celgene Corporation" with 6 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 5 trials as a collaborator, "Novartis" with 4 trials as a collaborator and "Roche Pharma AG" with 4 trials as a collaborator. Other collaborators include 175 different institutions and companies that were collaborators in the rest 157 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Edouard Herriot" are "Prostate Cancer" (16 trials), "Leukemia" (9 trials), "Acute Myeloid Leukemia" (7 trials), "Lymphoma" (6 trials) and "Myelodysplastic Syndromes" (6 trials). Many other conditions were trialed in "Hôpital Edouard Herriot" in a lesser frequency.

Most popular intervention types in "Hôpital Edouard Herriot" are "Drug" (210 trials), "Other" (82 trials), "Device" (52 trials), "Procedure" (38 trials) and "Biological" (37 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (38 trials), "cytarabine" (8 trials), "placebo" (8 trials), "cyclophosphamide" (7 trials) and "etoposide" (7 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Edouard Herriot" are 372 trials for "All" genders, 32 trials for "Male" genders and 13 trials for "Female" genders.

Currently, there are 101 active trials in "Hôpital Edouard Herriot". 5 are not yet recruiting, 71 are recruiting, 24 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 237 completed trials in Hôpital Edouard Herriot, undefined suspended trials, and 40 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Edouard Herriot, 6 "Phase 1" clinical trials were conducted, 78 "Phase 2" clinical trials and 132 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 17 trials, and there were also 94 trials that are defined as “Not Applicable".